Altre lingue Immuneering Corporation

Azioni

IMRX

US45254E1073

Tempo reale stimato Cboe BZX Altri mercati azionari 18:13:18 03/07/2024			Variaz. 5gg	Var. 1 gen.
1,13 ^USD	+3,67%		-18,12%	-84,63%

07/05	Immuneering Corporation riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
09/04	Immuneering Corporation presenta i dati preclinici al Meeting Annuale dell'Associazione Americana per la Ricerca sul Cancro	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Immuneering Corporation(NasdaqGM:IMRX) dropped from Russell Small Cap Comp Value Index	01/07
Immuneering Corporation(NasdaqGM:IMRX) dropped from Russell Small Cap Completeness Index	01/07
Immuneering Corporation(NasdaqGM:IMRX) dropped from Russell 3000E Index	01/07
Immuneering Corporation(NasdaqGM:IMRX) dropped from Russell 2500 Growth Index	01/07
Immuneering to Present at the Jefferies Global Healthcare Conference	29/05
Immuneering Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates	07/05
Immuneering Recognizes Melanoma Awareness Month	06/05
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models	09/04
Immuneering Corporation Presents Preclinical Data At the American Association for Cancer Research Annual Meeting	09/04
Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference	03/04
Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations	27/03
Immuneering Announces First Patient Dosed in its Phase 1/2a Trial of IMM-6-415 to Treat Advanced Solid Tumors with RAF or RAS Mutations	27/03
Immuneering Announces First Patient Dosed in Its Phase 1/2A Trial of Imm-6-415 to Treat Advanced Solid Tumors with Raf or Ras Mutations	27/03
March Madness Market Movers: INBS, NCMI, CIFR, IMRX, STI	20/03
North American Morning Briefing : Investors -2-	18/03
Sector Update: Health Care Stocks Ease Late Afternoon	15/03
Sector Update: Health Care	15/03
Immuneering Shares Decline After Analysts Downgrades, Phase 1 Cancer Therapy Data	15/03
North American Morning Briefing : Inflation -2-	15/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Immuneering Corporation

Azioni

IMRX

US45254E1073

Altre lingue

Filtri